The coagulopathy of cancer

Falanga A, Russo L, Milesi V.

Curr Opin Hematol. 2014;21(5):423-9.

7th international conference on thrombosis and hemostasis issues in cancer. Preface

Falanga A, Brenner B, Rickles FR.

Thromb Res. 2014;133 Suppl 2:ix.

Thrombosis in myeloproliferative neoplasms

Falanga A, Marchetti M.

Semin Thromb Hemost. 2014;40(3):348-58.

PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo

Catucci I, Peterlongo P, Ciceri S, Colombo M, Pasquini G, Barile M, Bonanni B, Verderio P, Pizzamiglio S, Foglia C, Falanga A, Marchetti M, Galastri L, Bianchi T, Corna C, Ravagnani F, Bernard L, Fortuzzi S, Sardella D, Scuvera G, Peissel B, Manoukian S, Tondini C, Radice P.

Genet Med. 2014;16(9):688-94.

Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia

Marchetti M, Tartari CJ, Russo L, Panova-Noeva M, Leuzzi A, Rambaldi A, Finazzi G, Woodhams B, Falanga A.

Am J Hematol. 2014;89(1):68-73.

Myeloproliferative neoplasms and thrombosis

Barbui T, Finazzi G, Falanga A.

Blood. 2013;122(13):2176-84